扶正通络方通过调控JAK2/STAT3通路促进自噬并减轻特发性肺纤维化
本研究在博来霉素诱导的肺纤维化大鼠模型和TGF-β诱导的肺成纤维细胞模型中探讨扶正通络方(FZTL)的作用机制。结果显示FZTL可减轻大鼠肺损伤、抑制炎症与纤维化形成,并促进自噬、抑制成纤维细胞活化;转录组学提示其作用经JAK2/STAT3通路介导,JAK2/STAT3激活剂白细胞介素6可抑制FZTL的抗成纤维细胞活化效应。
要点
- FZTL可减轻博来霉素诱导的大鼠肺纤维化损伤和炎症反应。
- FZTL促进自噬并抑制肺成纤维细胞活化,作用经JAK2/STAT3通路介导。
- JAK2/STAT3激活剂白细胞介素6可抵消FZTL的抗成纤维细胞活化效应。
核心结论
- 扶正通络方(FZTL)可抑制特发性肺纤维化损伤和肺成纤维细胞活化,其效应经JAK2/STAT3信号通路介导。
- FZTL可能是肺纤维化的潜在补充治疗。
研究设计与样本
- 采用博来霉素诱导的肺纤维化大鼠模型和转化生长因子-β诱导的肺成纤维细胞模型。
- 大鼠模型经FZTL治疗后检测组织学变化和纤维化形成,并评估自噬和肺成纤维细胞活化。
- 通过转录组学分析探索FZTL的作用机制。
主要发现
- FZTL减轻大鼠IPF损伤,抑制炎症反应和纤维化形成。
- FZTL在体外促进自噬并抑制肺成纤维细胞活化。
- 转录组学分析显示FZTL调控Janus激酶2(JAK)/信号转导与转录激活因子3(STAT)信号通路。
- JAK2/STAT3信号激活剂白细胞介素6抑制FZTL的抗成纤维细胞活化效应。
- JAK2抑制剂(AZD1480)与自噬抑制剂(3-甲基腺嘌呤)联合处理未增强FZTL的抗纤维化效应。
临床怎么用
- FZTL可作为肺纤维化的潜在补充治疗,其机制涉及调控JAK2/STAT3通路和促进自噬。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
ETHNOPHARMACOLOGICAL RELEVANCE: Fu-Zheng-Tong-Luo (FZTL) formula is a Chinese herbal prescription which is used to treat idiopathic pulmonary fibrosis (IPF). We previously reported that the FZTL formula could improve IPF injury in rats; however, the mechanism remains unelucidated. AIM OF THE STUDY: To elucidate the effects and mechanisms of the FZTL formula on IPF. MATERIALS AND METHODS: The bleomycin-induced pulmonary fibrosis rat model and transforming growth factor-β-induced lung fibroblast model were used. Histological changes and fibrosis formation were detected in the rat model after treatment with the FZTL formula. Furthermore, the effects of the FZTL formula on autophagy and lung fibroblast activation were determined. Moreover, the mechanism of FZTL was explored using transcriptomics analysis. RESULTS: We observed that FZTL alleviated IPF injury in rats and inhibited inflammatory responses and fibrosis formation in rats. Moreover, it promoted autophagy and inhibited lung fibroblast activation in vitro. Transcriptomics analysis revealed that FZTL regulates the Janus kinase 2 (JAK)/signal transducer and activator of the transcription 3 (STAT) signaling pathway. The JAK2/STAT3 signaling activator interleukin 6 inhibited the anti-fibroblast activation effect of the FZTL formula. Combined treatment with the JAK2 inhibitor (AZD1480) and autophagy inhibitor (3-methyladenine) did not enhance the antifibrotic effect of FZTL. CONCLUSIONS: The FZTL formula can inhibit IPF injury and lung fibroblast activation. Its effects are mediated via the JAK2/STAT3 signaling pathway. The FZTL formula may be a potential complementary therapy for pulmonary fibrosis.
引用
- Zhang X, Su J, Lin J, et al. Fu-Zheng-Tong-Luo formula promotes autophagy and alleviates idiopathic pulmonary fibrosis by controlling the Janus kinase 2/signal transducer and activator of transcription 3 pathway. J Ethnopharmacol. 2023. PMID: 37207878. doi:10.1016/j.jep.2023.116633
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。